Table 2.

Pre-treatment predictors of response in the remission and non-remission groups at 6 weeks

	Remission group (n=9)	Non-remission group (n=17)	P-value
Age, median (range), y	48 (21–73)	49 (19–77)	0.526
Sex (male/female)	8/1	11/6	0.329
Disease duration of UC, median (range), y	5.2 (0.5–31.0)	4.0 (1.0–41.6)	0.529
Pancolitis, n (%)	5 (56)	14 (83)	0.281
Steroid resistance, n (%)	3 (33)	8 (47)	0.427
Prior use of TNFα antagonists: none, n (%)	5 (56)	8 (47)	0.598
1 agent, n (%)	3 (33)	7 (41)	0.522
2 agents, n (%)	1 (11)	2 (12)	0.519
WBC, median (range), /μL	8100 (5500–19500)	7000 (3300–12200)	0.443
Hb, median (range), g/dL	14.0 (9.6–14.5)	11.8 (8.7–17.4)	0.178
Alb, median (range), g/dL	3.8 (2.5–4.2)	3.7 (2.1–4.6)	0.563
Plt, median (range), 103/μL	276 (172–522)	315 (122–549)	0.397
CRP, median (range), mg/dL	0.44 (0.02–7.98)	0.16 (0–3.93)	0.199
ESR per hour, median (range), mm	22.0 (9–63)	18.0 (2–70)	0.535
CAI score, median (range)	6 (4–14)	7 (4–13)	0.543
UCEIS, median (range)	4 (3–7)	4 (3–6)	0.526

UC: ulcerative colitis

TNFα: tumor necrosis factors alpha

WBC: white blood cell

Hb: hemoglobin

Alb: albumin

Plt: platelet

CRP: C-reactive protein

ESR: erythrocyte sedimentation rate

CAI: Clinical Activity Index

UCEIS: Ulcerative Colitis Endoscopic Index of Severity